63rd Annual Meeting of the Japanese Society of Neurology

Session information

Oral Presentation Award Nominee Session (Basic Research)

[AO-01] Oral Presentation Award Nominee Session (Basic Research)

Wed. May 18, 2022 3:35 PM - 5:05 PM Room3 (Tokyo International Forum B Block 7F Hall B7 1)

Chair:Nobutaka Hattori(Department of Neurology, Juntendo University)

Kotaro Oiwa1,2, Seiji Watanabe2, Kazunari Onodera1,3, Yohei Iguchi1, Yohei Okada3, Masahisa Katsuno1, Koji Yamanaka2 (1.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 2.Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Japan, 3.Department of Neurology, Aichi Medical University School of Medicine)

Hideki Tokuoka1,2, Rieko Imae3, Hitomi Nakashima2, Hiroshi Manya3, Chiaki Masuda4, Shunsuke Hoshino3, Kazuhiro Kobayashi2, Lefeber Dirk5, Riki Matsumoto1, Takashi Okada6, Tamao Endo3, Motoi Kanagawa2,7, Tatsushi Toda8 (1.Division of Neurology, Kobe University Graduate School of Medicine, Japan, 2.Division of Molecular Brain Science, Kobe University Graduate School of Medicine, Japan, 3.Molecular Glycobiology, Research Team for Mechanism of Aging, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 4.Department of Biochemistry and Molecular Biology, Nippon Medical School, 5.Department of Neurology, Radboud University Medical Center, 6.Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, 7.Department of Cell Biology and Molecular Medicine, Ehime University Graduate School of Medicine, 8.Department of Neurology, Graduate School of Medicine, The University of Tokyo)

Hideaki Nishihara1,2, Perriot Sylvain3, Gastfriend Benjamin4, Mathias Amandine3, Palecek Sean4, Shusta Eric4,5, Du Pasquier Renaud3, Takashi Kanda6, Engelhardt Britta2 (1.Department of Neurotherapeutics, Yamaguchi University, Japan, 2.Theodor Kocher Institute, University of Bern, 3.Laboratory of Neuroimmunology, University of Lausanne, Lausanne, Switzerland, 4.Department of Chemical and Biological Engineering, University of Wisconsin-Madison, WI, USA, 5.Department of Neurological Surgery, University of Wisconsin-Madison, WI, USA, 6.Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan)

Yutaka Oji1, Taku Hatano1, Kazutaka Ikeda2, Risa Nonaka3, Kei-ichi Ishikawa1,3, Ryo Wakamori1, Kentaro Gejima1, Shin-ichi Ueno1, Ayami Okuzumi1, Wado Akamatsu3, Nobutaka Hattori1 (1.Department of Neurology, Juntendo University School of Medicine, Japan, 2.Laboratory of Biomolecule Analysis, Kazusa DNA Research Institute, 3.Center for Genomic and Regenerative Medicine, Juntendo University School of Medine)

Yoshiki Takai1, Tatsuro Misu1, Chihiro Namatame1, Yuki Matsumoto1, Kimihiko Kaneko1, Toshiyuki Takahashi1,2, Kazuo Fujihara3, Masashi Aoki1 (1.Department of Neurology, Tohoku University Hospital, Japan, 2.Department of Neurology, National Hospital Organization Yonezawa National Hospita, 3.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University)